Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
NCT00433602 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2013-06-12
Summary
RATIONALE: Chemotherapy may cause blood clots to form in the thigh, leg, and lung. This study may help doctors understand how often blood clots occur in patients undergoing chemotherapy.
PURPOSE: This clinical trial is studying how often blood clots occur in patients undergoing chemotherapy for solid tumors, including colorectal cancer, stomach cancer, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, or metastatic breast cancer
Conditions
Interventions
- OTHER
-
clinical observation
- PROCEDURE
-
management of therapy complications
- PROCEDURE
-
ultrasound imaging
Sponsors & Collaborators
-
European Organisation for Research and Treatment of Cancer - EORTC
lead NETWORK
Principal Investigators
-
Hans-Martin Otten, MD · Slotervaart Ziekenhuis
-
Ullrich Bethe, MD · European Organisation for Research and Treatment of Cancer - EORTC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-11-30
- Primary Completion
- 2007-03-31
Countries
- Netherlands
Study Locations
More Related Trials
-
A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
NCT00320255 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer
NCT02412670 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes
NCT00490659 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer
NCT02006667 ·Status: COMPLETED ·Phase: PHASE2
-
Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00016367 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
NCT00005086 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00006372 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT00402051 ·Status: COMPLETED ·Phase: PHASE2
-
S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
NCT00022633 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of Humeral or Thoracic Implantation of an Central Veinous Access by an Implantable Venous Access Device in Patients With Solid Tumors Requiring Chemotherapy
NCT03410121 ·Status: COMPLETED ·Phase: NA
-
Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
NCT05874063 ·Status: RECRUITING ·Phase: PHASE3
-
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
NCT00620295 ·Status: COMPLETED ·Phase: PHASE1
-
Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer
NCT00020644 ·Status: UNKNOWN ·Phase: PHASE1
-
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
NCT00002608 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC
NCT00463515 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00005068 ·Status: COMPLETED ·Phase: PHASE1
-
Study of GemOx and Vandetanib in Advanced Solid Malignancy
NCT00660725 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer
NCT05550415 ·Status: RECRUITING ·Phase: PHASE2
-
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT00004095 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
NCT00009815 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
NCT06447662 ·Status: RECRUITING ·Phase: PHASE1
-
Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer
NCT00544063 ·Status: UNKNOWN ·Phase: PHASE1
-
Adjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric Cancer
NCT02672865 ·Status: COMPLETED ·Phase: PHASE1
-
Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
NCT00072332 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients
NCT01172470 ·Status: COMPLETED ·Phase: PHASE2